Answers are grounded in this paper and cite their sources.
A platform uncovers shared drug-resistance mechanisms in skin-cancer cells, indicating common pathways for treatment.
A platform for tracking the changes in gene expression and chromatin accessibility that follow interference with specific genes has been developed. The platform, called PerturbFate, was applied to skin-cancer cells and showed that different genetic perturbations associated with tumour resistance push cells into a shared dedifferentiated state. Many genetic perturbations that cause resistance to an anticancer drug do so through common pathways.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: